Stocks Mentioned: Veritas Pharma Inc. (CSE: $VRT.C; OTC: $VRTHF), Zynerba (NASDAQ: $ZYNE),GW Pharmaceuticals (NASDAQ: $GWPH),Tetra Bio-Pharma (TSXV: $TBP.V; $TBPMF), Aphria Inc (TSX: $APH.TO; $APHQF)
Point Roberts, WA, November 21, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks issues a sector news alert on companies with new drug discoveries and developments in the sector.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/11212CannabisStocks.asp
How will cannabis impact the big pharma industry moving forward? According to a study by the University of Georgia entitled ‘Medical Marijuana Laws Reduce Prescription Medication Use in Medicare Part D’, it will lower costs.
“The savings, due to lower prescription drug use, were estimated to be $165.2 million in 2013, a year when 17 states and the District of Columbia had implemented medical marijuana laws. The results suggest that if all states had implemented medical marijuana the overall savings to Medicare would have been around $468 million.”
- Published: 22 November 2017
- Written by Investor Ideas